These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29733742)

  • 1. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B; Winstock AR; Erritzoe D; Maier LJ
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
    Laursen HR; Henningsson S; Macoveanu J; Jernigan TL; Siebner HR; Holst KK; Skimminge A; Knudsen GM; Ramsoy TZ; Erritzoe D
    J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance and serotonergic function in users of ecstasy.
    Verkes RJ; Gijsman HJ; Pieters MS; Schoemaker RC; de Visser S; Kuijpers M; Pennings EJ; de Bruin D; Van de Wijngaart G; Van Gerven JM; Cohen AF
    Psychopharmacology (Berl); 2001 Jan; 153(2):196-202. PubMed ID: 11205419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
    Buchert R; Thomasius R; Nebeling B; Petersen K; Obrocki J; Jenicke L; Wilke F; Wartberg L; Zapletalova P; Clausen M
    J Nucl Med; 2003 Mar; 44(3):375-84. PubMed ID: 12621003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in moderate MDMA use: A systematic review.
    Mueller F; Lenz C; Steiner M; Dolder PC; Walter M; Lang UE; Liechti ME; Borgwardt S
    Neurosci Biobehav Rev; 2016 Mar; 62():21-34. PubMed ID: 26746590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.